The abstract is read at the publisher; the summary is JClub's.
IGF2BP1 promotes lymphatic metastasis in gastric cancer by stabilizing METTL21A mRNA, enabling SOX18 nuclear translocation and CXCL12-driven lymphangiogenesis via CXCR4 signaling.
- Why it matters: Lymph node metastasis in gastric cancer worsens prognosis, but the m6A-linked molecular pathway connecting post-transcriptional regulation to lymphangiogenic transcriptional activation was unclear.
- What they did: The study used gastric cancer tissues and functional assays in lymphatic endothelial cells, showing IGF2BP1 binds the m6A-modified METTL21A 3'UTR to increase METTL21A expression; METTL21A methylates SOX18 to drive nuclear translocation and CXCL12 transcription.
- The result: METTL21A knockout abolished IGF2BP1-induced lymphangiogenesis, and SOX18 depletion eliminated IGF2BP1’s pro-lymphangiogenic effects, supporting the IGF2BP1–METTL21A–SOX18–CXCL12 axis as a therapeutic target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.